Mr. Kenneth M. Bate has been the Chairman of the company since 2021. Prior to this, he served as Director of the company since 2007. Previously, Mr. Bate has served as President and Chief Executive Officer of Archemix, Inc since 2009 and as President and Chief Executive Officer of Nitromed, Inc since 2006. He has also been the Chief Financial Officer and head of commercial operations of Millennium Pharmaceuticals Inc in 2005. Mr. Bate is currently on the Board of Catabasis Pharmaceuticals, Inc. Genocea Biosciences, Inc., TransMedics, Inc., and Epizyme, Inc.

Mr. Jeong serves is the Chief Financial Officer of the company. Prior to this, he has served as a financial and accounting officer at LG Chem, Ltd. since 1999. Before this, Mr. Jeong has served as the financial director and controller for several entities where LG Chem invested in joint ventures and/or subsidiaries, the majority of them in Thailand.

Mr. Jebediah Ledell has been the Chief Operating Officer of the company since 2021. Previously he served as Chief Operating Officer of the company. Prior to that he served as the chief operating officer of Compass Therapeutics, Inc

Mr. Edgar E. Braendle, MD, PhD has been the Chief Medical Officer of the company since March 2024. Prior to this he served as serving as Chief Development Officer of Autolus Therapeutic.

Mr. Mike Ferraresso has been the Chief Commercial Officer of the company since 2017. Prior to this, he has been the Senior Vice President of Business Analytics and Commercial Operations. Previously, he has served in sales and commercial operations roles at several biotechnology and pharmaceutical companies, including at Infinity Pharmaceuticals, AMAG Pharmaceuticals, Verastem, Praecis Pharmaceuticals, Critical Therapeutics, Muro Pharmaceuticals, and Ascent Pediatrics.